MedPath

HRQOL of Life After ECMO Due to COVID-19.

Not Applicable
Recruiting
Conditions
COVID-19 Pneumonia
ARDS
Extracorporeal Membrane Oxygenation
Registration Number
NCT05531032
Lead Sponsor
Medical University of Vienna
Brief Summary

We intend to prospectively investigate physical and mental state (HRQOL) by means of quantitative telephone interviews after hospital discharge in patients surviving COVID-19 ARDS and ECMO therapy.

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
44
Inclusion Criteria
  • patients surviving COVID-19 ARDS and ECMO therapy
Read More
Exclusion Criteria
  • no consent
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Primary Outcome Measures
NameTimeMethod
HRQOL after COVID-19 ARDS and ECMO therapy1 year

Health-related quality of life will be delineated by means of a quantitative questionnaire.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Medical University of Vienna

🇦🇹

Vienna, Austria

© Copyright 2025. All Rights Reserved by MedPath